Americas

Innovation power is playing a critical role in today’s world order, affecting global economies, militaries, and societies. Panelists discuss the strategy needed for the United States to compete in this space to ensure its national security, economic prosperity, and global influence.  

The COVID-19 pandemic and chronic U.S. drug shortages highlight the health security and strategic importance of U.S. pharmaceutical and biotechnology capabilities during and between pathogenic crises. Geopolitical competition and interest in industrial policy for biotechnology further underscore the national security role of domestic biopharmaceutical infrastructure. Policymakers confront competing health, economic, and strategic priorities in maximizing innovation in technology, business models, and health-care systems in facilitating safe, accessible, secure, and sustainable products, services, and supply chains.   Please join our speakers, Monique K. Mansoura, executive director for global health security and biotechnology at The MITRE Corporation, and Victor Suarez, Colonel (ret.), U.S. Army, senior fellow (visiting) at The Council on Strategic Risks and founder of BluZoneBio, to explore challenges facing the U.S. pharma and biotech industries and approaches to strengthening the national security resilience of those industries in a world marked by health and geopolitical threats.

The C. Peter McColough Series on International Economics brings the world's foremost economic policymakers and scholars to address members on current topics in international economics and U.S. monetary policy. This meeting series is presented by RealEcon: Reimagining American Economic Leadership, a CFR initiative of the Maurice R. Greenberg Center for Geoeconomic Studies. For those attending virtually, log-in information and instructions on how to participate during the question and answer portion will be provided the evening before the event to those who register. Please note the audio, video, and transcript of this meeting will be posted on the CFR website.

The Netflix series Turning Point: The Bomb and the Cold War is an exploration of the decades-long conflict between the United States and the Soviet Union framed by current events that reveal the Cold War continues and the world remains on the precipice of nuclear war. Join us for a special screening of episode nine of the series, followed by a discussion on the ongoing danger posed by nuclear weapons amidst present-day conflicts and how recent advancements, including artificial intelligence, influence the risks related to nuclear warfare. The full series of Turning Point: The Bomb and the Cold War is out on Netflix now.  The Paul C. Warnke Lecture on International Security was established in 2002 and is endowed by a number of Council members and the family and friends of Paul C. Warnke. The lecture commemorates his legacy of courageous service to the nation and international peace.

In response to COVID-19, member states of the World Health Organization (WHO) have been negotiating to create a pandemic agreement and to amend the existing International Health Regulations (IHR). The negotiations have been closely watched as indicators of global health diplomacy's future in an increasingly divided world. On June 1, the WHO's World Health Assembly approved amendments to the IHR and extended negotiations on a pandemic agreement. Dr. Suerie Moon, codirector of the Global Health Centre at the Graduate Institute of International and Development Studies in Geneva; David Fidler, senior fellow for global health and cybersecurity at the Council on Foreign Relations (CFR); and presider Thomas J. Bollyky, Bloomberg Chair in Global Health at CFR discuss what the World Health Assembly's decisions on the IHR amendments and the pandemic agreement negotiations mean for global health security, equity, and governance.